down arrow

Poly Medicure

  • Market Cap: Large Cap
  • Industry: Medical Equipment/Supplies/Accessories
  • ISIN: INE205C01021
  • NSEID: POLYMED
  • BSEID: 531768
INR
2,134.10
97.7 (4.8%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 54.92 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

2,060.002,139.95

52 Week

1,493.353,350.00
Valuation
Technical
Day's Volume

CASH

54.92 k (17.36%) Volume

Shareholding (Sep 2024)

FII

11.86%

Held by 179 FIIs

DII

12.35%

Held by 16 DIIs

Promoter

62.56%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Stock is technically in a Bearish range

  • The technical trend has deteriorated from Mildly Bearish on 04-Apr-25 and has generated 2.42% returns since then
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
2

With ROE of 11.4, it has a Very Expensive valuation with a 8 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Medical Equipment/Supplies/Accessories

stock-summary
Market cap

INR 21,624 Cr (Large Cap)

stock-summary
P/E

65.00

stock-summary
Industry P/E

53

stock-summary
Dividend Yield

0.15%

stock-summary
Debt Equity

-0.42

stock-summary
Return on Equity

11.38%

stock-summary
Price to Book

7.96

Revenue and Profits (1 Year):
Net Sales:
424 Cr
(Quarterly Results - Dec 2024)
Net Profit:
85 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.15%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-8.96%
0%
-8.96%
1 Year
36.98%
0.18%
37.16%
2 Years
126.78%
0.61%
127.39%
3 Years
136.43%
1.15%
137.58%
4 Years
142.59%
1.10%
143.69%
5 Years
739.54%
4.27%
743.81%

Latest dividend: 3 per share ex-dividend date: Sep-19-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
18.49%
EBIT Growth (5y)
24.66%
EBIT to Interest (avg)
48.87
Debt to EBITDA (avg)
0.61
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.83
Tax Ratio
25.36%
Dividend Payout Ratio
11.15%
Pledged Shares
0
Institutional Holding
23.99%
ROCE (avg)
21.33%
ROE (avg)
15.61%
Valuation key factors
Factor
Value
P/E Ratio
65
Industry P/E
53
Price to Book Value
7.96
EV to EBIT
55.50
EV to EBITDA
45.41
EV to Capital Employed
13.02
EV to Sales
12.16
PEG Ratio
3.28
Dividend Yield
0.15%
ROCE (Latest)
22.20%
ROE (Latest)
11.38%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 19 Schemes (7.35%)

FIIs

Held by 179 FIIs (11.86%)

Promoter with highest holding

Ezekiel Global Business Solutions Llp (12.2%)

Highest Public shareholder

Quant Mutual Fund - Quant Large Cap Fund (3.51%)

Individual Investors Holdings

10.14%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 24.91% vs 19.23% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 31.08% vs 30.01% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "424.21",
          "val2": "339.60",
          "chgp": "24.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "114.54",
          "val2": "90.22",
          "chgp": "26.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.33",
          "val2": "3.47",
          "chgp": "-4.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "85.23",
          "val2": "65.02",
          "chgp": "31.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.00%",
          "val2": "26.57%",
          "chgp": "0.43%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 22.29% vs 25.70% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 29.31% vs 77.25% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "804.79",
          "val2": "658.12",
          "chgp": "22.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "219.24",
          "val2": "171.42",
          "chgp": "27.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.50",
          "val2": "4.71",
          "chgp": "38.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "161.49",
          "val2": "124.89",
          "chgp": "29.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.24%",
          "val2": "26.05%",
          "chgp": "1.19%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 23.18% vs 23.42% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 29.91% vs 57.64% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,229.00",
          "val2": "997.72",
          "chgp": "23.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "333.78",
          "val2": "261.64",
          "chgp": "27.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "9.83",
          "val2": "8.18",
          "chgp": "20.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "246.72",
          "val2": "189.91",
          "chgp": "29.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.16%",
          "val2": "26.22%",
          "chgp": "0.94%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 23.36% vs 20.82% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 44.05% vs 22.37% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,375.80",
          "val2": "1,115.23",
          "chgp": "23.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "358.23",
          "val2": "265.39",
          "chgp": "34.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "11.30",
          "val2": "8.84",
          "chgp": "27.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "258.26",
          "val2": "179.28",
          "chgp": "44.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.04%",
          "val2": "23.80%",
          "chgp": "2.24%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
424.21
339.60
24.91%
Operating Profit (PBDIT) excl Other Income
114.54
90.22
26.96%
Interest
3.33
3.47
-4.03%
Exceptional Items
0.00
0.00
Consolidate Net Profit
85.23
65.02
31.08%
Operating Profit Margin (Excl OI)
27.00%
26.57%
0.43%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 24.91% vs 19.23% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 31.08% vs 30.01% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
804.79
658.12
22.29%
Operating Profit (PBDIT) excl Other Income
219.24
171.42
27.90%
Interest
6.50
4.71
38.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
161.49
124.89
29.31%
Operating Profit Margin (Excl OI)
27.24%
26.05%
1.19%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 22.29% vs 25.70% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 29.31% vs 77.25% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,229.00
997.72
23.18%
Operating Profit (PBDIT) excl Other Income
333.78
261.64
27.57%
Interest
9.83
8.18
20.17%
Exceptional Items
0.00
0.00
Consolidate Net Profit
246.72
189.91
29.91%
Operating Profit Margin (Excl OI)
27.16%
26.22%
0.94%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 23.18% vs 23.42% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 29.91% vs 57.64% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
1,375.80
1,115.23
23.36%
Operating Profit (PBDIT) excl Other Income
358.23
265.39
34.98%
Interest
11.30
8.84
27.83%
Exceptional Items
0.00
0.00
Consolidate Net Profit
258.26
179.28
44.05%
Operating Profit Margin (Excl OI)
26.04%
23.80%
2.24%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 23.36% vs 20.82% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 44.05% vs 22.37% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Poly Medicure Ltd stock-summary
stock-summary
Poly Medicure Ltd
Large Cap
Medical Equipment/Supplies/Accessories
Poly Medicure Limited was incorporated on 30th March 1995. The Company is a manufacturer/producer of Medical Devices. It manufactures and supply, in India and internationally, a diverse portfolio of medical devices in the product verticals of infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices and others.
Company Coordinates stock-summary
Company Details
Property No 232B 3rd Floor, Okhla Indl Estate Phase-III New Delhi New Delhi : 110020
stock-summary
Tel: 91-11-26321838/81/89/93
stock-summary
http://www.polymedicure.com
stock-summary
investorcare@polymedicure.com
Registrar Details
MAS Services Ltd, T-34 , 2nd Floor, Okhla Industrial Area, Phase - II, New Delhi
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."